🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate the effectiveness of prop...
Status
Terminated
Location
Research Site
Start Date
2015-07
Trial ID
NCT02392156
Treatments Being Tested
This trial will enroll patients with severe hemophilia A. Experiments will ...
Status
Completed
Location
Tulane University Lakeside Hospital and Clinics
Start Date
2022-08-01
Trial ID
NCT05281718
Treatments Being Tested
Primary: To characterize the safety of RIXUBIS when used under normal clini...
Status
Completed
Location
Daegu Catholic University Medical Center
Start Date
2017-01-06
Trial ID
NCT02922231
Treatments Being Tested
Primary Objective: To evaluate the safety (acute effects associated with i...
Status
Completed
Location
City of Hope
Start Date
2009-01
Trial ID
NCT00768287
Treatments Being Tested
This trial is conducted in Europe, Japan and the United States of America (...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2009-08
Trial ID
NCT00956345
Treatments Being Tested
Recombinant factor VIII Fc (rFVIIIFc) and recombinant factor IX Fc (rFIXFc)...
Status
Completed
Location
BC Hemophilia Adult Program
Start Date
2016-04
Trial ID
NCT02796222
The purpose of this pivotal Phase 1/3 study is to determine the pharmacokin...
Status
Completed
Location
Multiple Locations
Start Date
2010-07-29
Trial ID
NCT01174446
The purpose of this BAX 326 Continuation Study is to further investigate in...
Status
Completed
Location
Instituto de Hematología y Medicina Clíncia Rubén Dávoli
Start Date
2011-04-12
Trial ID
NCT01286779
Treatments Being Tested
The primary objective of this clinical research study is to establish the b...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00093210
The purpose of this study is to characterize the safety and describe the ef...
Status
Completed
Location
Sahyadri Super Speciality Hospital
Start Date
2018-12-07
Trial ID
NCT03565237
Treatments Being Tested